相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants
Cynthia Hsu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu et al.
GUT (2019)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective, single-arm trial (LEAD trial)
Yoshio Sumida et al.
HEPATOLOGY RESEARCH (2019)
Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial
Paola Portillo-Sanchez et al.
JOURNAL OF DIABETES (2019)
Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
Rohit Loomba et al.
GASTROENTEROLOGY (2019)
A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis
Takeshi Okanoue et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Current and future pharmacological therapies for NAFLD/NASH
Yoshio Sumida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging
Yingzhen N. Zhang et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein
Masanori Atsukawa et al.
HEPATOLOGY RESEARCH (2018)
Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
Michiharu Komatsu et al.
HEPATOLOGY RESEARCH (2018)
To die or not to die: death signaling in nonalcoholic fatty liver disease
Yuko Akazawa et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease
Yuji Ogawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Should we undertake surveillance for HCC in patients with NAFLD?
Ramy Younes et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
The gut-liver axis and the intersection with the microbiome
Anupriya Tripathi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
Takefumi Kimura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
Naoyuki Fujimori et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Hannah E. Da Silva et al.
SCIENTIFIC REPORTS (2018)
Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score)
Witigo von Schoenfels et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun Sanyal et al.
LANCET (2018)
Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease
Monika Rau et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Current status of imaging in nonalcoholic fatty liver disease
Qian Li et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Natural History of Nonalcoholic Fatty Liver Disease: A Prospective Follow-Up Study With Serial Biopsies
Patrik Nasr et al.
HEPATOLOGY COMMUNICATIONS (2018)
Management of Nonalcoholic Fatty Liver Disease: Lessons Learned From Type 2 Diabetes
Naim Alkhouri et al.
HEPATOLOGY COMMUNICATIONS (2018)
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
Takefumi Kimura et al.
HEPATOLOGY RESEARCH (2017)
Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
Michiie Sakamoto et al.
PATHOLOGY INTERNATIONAL (2017)
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero-Gómez et al.
JOURNAL OF HEPATOLOGY (2017)
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang et al.
NATURE MEDICINE (2017)
Novel therapeutic strategies targeting ASK1 in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Targeting nuclear receptors for the treatment of fatty liver disease
Naoki Tanaka et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
Hiroyuki Kitabatake et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Brandon J. Perumpail et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet
Naoki Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease
Noam Peleg et al.
DIGESTIVE AND LIVER DISEASE (2017)
Use of Mac-2 Binding Protein as a Biomarker for Nonalcoholic Fatty Liver Disease Diagnosis
Yoshihiro Kamada et al.
HEPATOLOGY COMMUNICATIONS (2017)
Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency
Marinos Pericleous et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Nonalcoholic Fatty Liver Disease and the Ongoing Role of Liver Biopsy Evaluation
Elizabeth M. Brunt
HEPATOLOGY COMMUNICATIONS (2017)
Effects of a Sodium-Glucose Cotransporter 2 Inhibitor in Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus: Preliminary Prospective Study Based On Serial Liver Biopsies
Norio Akuta et al.
HEPATOLOGY COMMUNICATIONS (2017)
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S. A. Harrison et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Development and Validation of a Noninvasive Prediction Model for Nonalcoholic Steatohepatitis Resolution After Lifestyle Intervention
Eduardo Vilar-Gomez et al.
HEPATOLOGY (2016)
Diet, Weight Loss, and Liver Health in Nonalcoholic Fatty Liver Disease: Pathophysiology, Evidence, and Practice
Giulio Marchesini et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis
Naoyuki Fujimori et al.
HEPATOLOGY RESEARCH (2016)
FibroGENE: A gene-based model for staging liver fibrosis
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
Carrie R. Wong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα
Michiharu Komatsu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet
Naoki Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation
Limin Zhang et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2015)
The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH
Rohit Loomba et al.
GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Sumio Watanabe et al.
HEPATOLOGY RESEARCH (2015)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Sumio Watanabe et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma
Carlo Saitta et al.
LIVER INTERNATIONAL (2015)
Prevalence of fatty liver disease and the economy in China: A systematic review
Jin-Zhou Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Liver fibrosis markers of nonalcoholic steatohepatitis
Hirayuki Enomoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges
Etsuko Hashimoto et al.
HEPATOLOGY RESEARCH (2015)
Adipocyte-specific Disruption of Fat-specific Protein 27 Causes Hepatosteatosis and Insulin Resistance in High-fat Diet-fed Mice
Naoki Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
Tadanobu Nagaya et al.
BBA CLINICAL (2015)
Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet
Naoki Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Activated Hepatic Stellate Cells Are Dependent on Self-collagen, Cleaved by Membrane Type 1 Matrix Metalloproteinase for Their Growth
Naoko Kubo Birukawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Metabolically Healthy Obesity, Presence or Absence of Fatty Liver, and Risk of Type 2 Diabetes in Japanese Individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20)
Yoriko Heianza et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Body mass index in childhood and adult risk of primary liver cancer
Tina Landsvig Berentzen et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent
Lay T. Gan et al.
JOURNAL OF HEPATOLOGY (2014)
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshio Sumida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The liver diseases of lipodystrophy: The long-term effect of leptin treatment
Elika Safar Zadeh et al.
JOURNAL OF HEPATOLOGY (2013)
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Shin Yoshimoto et al.
NATURE (2013)
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
Yoshio Sumida et al.
BMC GASTROENTEROLOGY (2012)
Metabolomics Identifies an Inflammatory Cascade Involved in Dioxin- and Diet-Induced Steatohepatitis
Tsutomu Matsubara et al.
CELL METABOLISM (2012)
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
Naoki Tanaka et al.
HEPATOLOGY (2012)
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
Yuichiro Eguchi et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Kohichiroh Yasui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy
Naoki Tanaka et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
Masato Yoneda et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Masaru Tsutsui et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
Goro Tsuruta et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
Tomoko Hatta et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Tadanobu Nagaya et al.
JOURNAL OF HEPATOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC
Oscar Rubio-Cabezas et al.
EMBO MOLECULAR MEDICINE (2009)
Hepatic steatosis in leptin-deficient mice is promoted by the PPARγ target gene Fsp27
Kimihiko Matsusue et al.
CELL METABOLISM (2008)
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
S. A. Harrison et al.
GUT (2008)
Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
Naoki Tanaka et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease
Michiharu Komatsu et al.
JOURNAL OF HEPATOLOGY (2008)
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers
Indra Neil Guha et al.
HEPATOLOGY (2008)
Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case
Tadanobu Nagaya et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2008)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
Naoki Tanaka et al.
LIVER INTERNATIONAL (2006)
Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease
Hiroyuki Kaneda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
V Ratziu et al.
BMC GASTROENTEROLOGY (2006)
Laparoscopic findings in patients with nonalcoholic steatohepatitis
N Tanaka et al.
LIVER INTERNATIONAL (2006)
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
JA Marrero et al.
HEPATOLOGY (2002)